AmeriCann (ACAN) AI Stock Analysis

• Market Cap: $1.39M
• Dividend Yield: N/A
• Average Volume (3M): 8.74K
• Price to Earnings (P/E): ―
• Beta (1Y): -2.41
• Revenue Growth: -65.15%
• EPS Growth: -720.17%
• Country: US
• Employees: 3
• Sector: Real Estate
• Sector Strength: 69
• Industry: Real Estate - Services
• EPS (TTM): -0.10
• Shares Outstanding: 24,391,960
• 10 Day Avg. Volume: 2,043
• 30 Day Avg. Volume: 8,741
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 1.00
• Price to Cash Flow (P/CF): -0.30
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

AmeriCann's overall stock score is primarily driven by its financial performance challenges, with declining revenues, high leverage, and negative cash flows posing significant risks. Despite some positive technical indicators suggesting short-term strength, the stock's valuation remains concerning due to ongoing losses and no dividend yield. This combination of factors results in a low overall stock score, reflecting caution for potential investors.

AmeriCann Business Overview & Revenue Model

Company Description

AmeriCann (ACAN) is a company focused on the development and leasing of sustainable, state-of-the-art medical cannabis cultivation and processing facilities. The company operates primarily within the cannabis industry, offering infrastructure solutions for licensed cannabis operators. AmeriCann aims to advance the cannabis cultivation industry by providing advanced technology and sustainable practices in its facilities.

How the Company Makes Money

AmeriCann makes money primarily through leasing its cannabis cultivation and processing facilities to licensed operators. The company invests in the development of large-scale, efficient cannabis production facilities and enters into agreements with cannabis businesses to lease these spaces. Revenue is generated from rental income, which may be based on fixed lease payments, variable rent based on the tenant's sales performance, or a combination of both. Additionally, AmeriCann may form strategic partnerships with cannabis operators, potentially offering consulting services and facility management solutions to enhance tenant operations and maximize facility productivity.

AmeriCann Financial Statement Overview

Summary

AmeriCann faces significant financial challenges, including declining revenues, high leverage, and negative cash flows. The company needs to address its operational inefficiencies and manage its debt levels to improve financial health. Stability and profitability are currently weak, posing risks to future growth and sustainability.

Income Statement

The company shows a declining revenue trend with significant negative net income, indicating profitability challenges. Gross profit margin is high, but negative EBIT and EBITDA margins in the recent year reflect operational inefficiencies. The revenue growth rate is negative, showing a concerning trend.

Balance Sheet

The debt-to-equity ratio is high, indicating potential leverage risk. Stockholders' equity has decreased, weakening financial stability. The equity ratio is low, suggesting a higher proportion of assets financed by liabilities, which may pose a risk.

Cash Flow

The company has negative operating and free cash flows, indicating cash flow management issues. The free cash flow has significantly decreased, and operating cash flow to net income ratio is negative, reflecting operational cash flow challenges.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
2.85M	1.27M	2.55M	2.93M	2.03M	503.51K
	Gross Profit
2.80M	1.27M	2.54M	2.88M	1.99M	481.01K
	EBIT
400.70K	-745.61K	611.67K	482.73K	62.60K	147.13K
	EBITDA
931.30K	-171.97K	1.14M	1.01M	580.74K	660.86K
	Net Income Common Stockholders
-464.49K	-1.25M	-94.75K	-829.22K	-1.79M	-1.57M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
131.16K	48.84K	1.14M	1.34M	696.38K	183.01K
	Total Assets
10.14M	14.06M	15.15M	15.44M	15.06M	14.87M
	Total Debt
6.21M	8.70M	9.30M	9.30M	9.20M	8.56M
	Net Debt
6.08M	8.66M	8.16M	7.96M	8.50M	8.38M
	Total Liabilities
6.99M	9.61M	9.45M	9.64M	9.55M	8.99M
	Stockholders Equity
3.15M	4.45M	5.71M	5.80M	5.51M	5.87M
Cash Flow		Free Cash Flow
351.54K	-1.17M	300.69K	603.16K	-368.55K	131.85K
	Operating Cash Flow
632.57K	-1.17M	579.86K	848.74K	-275.15K	518.33K
	Investing Cash Flow
-244.88K	83.90K	-635.98K	-204.01K	-58.64K	-357.24K
	Financing Cash Flow
-300.00K	0.00	-150.00K	0.00	847.00K	-1.26M

AmeriCann Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.06
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACAN, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.03, and above the 200-day MA of 0.03, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.48 is Neutral, neither overbought nor oversold. The STOCH value of 61.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACAN.

AmeriCann Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IIPR	76 Outperform	$1.81B	11.54	8.20%	11.80%	-0.32%	-4.24%
CRON	68 Neutral	C$979.28M	17.25	3.80%	―	35.87%	―
Sector *	61 Neutral	$4.71B	17.72	-2.95%	11.43%	6.02%	-21.34%
ACAN	47 Neutral	$1.39M	―	-54.80%	―	-65.15%	-720.17%
SMG	46 Neutral	$3.15B	―	4.98%	4.82%	3.61%	94.27%
TLRY	44 Neutral	$621.38M	―	-7.28%	―	18.38%	86.59%
GRWG	43 Neutral	$66.00M	―	-33.74%	―	-16.39%	-9.08%